We studied suppressor cell function in 10 patients who had congestive cardiomyopathy, 13 patients who had myocarditis and 98 healthy controls. Myocardial biopsy, coronary arteriography and left ventricular angiography were used to define and differentiate congestive cardiomyopathy and myocarditis. The suppressor component of the immune response was assessed by examining the in vitro responses of peripheral blood lymphoid (PBL) cells under standard conditions. Briefly, PBL cells were incubated with concanavalin A to stimulate suppressor activity. Induced activity was measured by the ability of PBL cells to inhibit 'Hthymidine uptake of nonstimulated autologous cells when subsequently presented with allogenic or mitogenic stimuli.
SUMMARY We studied suppressor cell function in 10 patients who had congestive cardiomyopathy, 13 patients who had myocarditis and 98 healthy controls. Myocardial biopsy, coronary arteriography and left ventricular angiography were used to define and differentiate congestive cardiomyopathy and myocarditis. The suppressor component of the immune response was assessed by examining the in vitro responses of peripheral blood lymphoid (PBL) cells under standard conditions. Briefly, PBL cells were incubated with concanavalin A to stimulate suppressor activity. Induced activity was measured by the ability of PBL cells to inhibit 'Hthymidine uptake of nonstimulated autologous cells when subsequently presented with allogenic or mitogenic stimuli.
CARDIOMYOPATHIES are defined as heart muscle diseases of unknown cause. The widely used classification is based on clinical and pathologic anatomic criteria and distinguishes dilated, hypertrophic and restricted forms.'-3 This classification does not describe all aspects of a differing nosology. The so-called congestive cardiomyopathy (CCM) can be described by special morphologic, biochemical and immunologic events, which have only a moderate specificity. Thus, the separation between primary and secondary diseases is often not precise in clinical conditions.
Recently, 76% of patients in the acute phase of viral carditis were found to have myocardial antibodies by indirect immunofluorescence methods. Nuclearbound antiglobulin IgM was found in all of these patients.' In dilated cardiomyopathies, a high percentage of bound immunoglobulins could be detected in myocardial biopsy tissue. Immunoglobulin IgG was most often demonstrated in sarcolemmal structures of patients with low ejection fractions (<35%); in patients with higher ejection fractions, the percentage of binding was considerably lower.5 In studies with 8Hthymidine incorporation into the DNA of stimulated lymphocytes in the presence of concanavalin A-treated peripheral blood mononuclear cells, Fowles et al.6 found depressed suppressor cell function in patients with CCM.
B-lymphocytes synthesize humoral antibodies, which are found in the serum. Helper and suppressor T-cells modify this activity quantitatively. As a consequence of a diminished suppressor T-cell function, the physiologic control of the antibody synthesis could be disturbed. Subsequently, specifically acting pathologic agents could cause an excessive production of cardiotoxic antibodies, which may bind to myocardial structures.
The natural history and the pathogenesis of CCM and myocarditis (MC) are unclear, and whether there is a relationship between the pathogenesis of these two diseases has not been resolved. Therefore, we compared the suppressor cell function in patients with CCM and MC and in clinically healthy controls.
Materials and Methods Probands
The CCM group included 10 patients, eight males and two females, ages 26-66 years, with a clinical diagnosis of congestive heart failure without detectable etiology, a decreased ejection fraction, an increased end-diastolic volume in most cases, and a morphologic analysis of an endomyocardial biopsy compatible with CCM (table 1). According to the terminology of Olsen,7 the morphologic criteria characteristic of congestive cardiomyopathies are attenuated muscle fibers, interstitial fibrosis and morphologic signs of muscle hypertrophy and dilatation.
The MC group included 13 patients, nine males and four females, ages 34-64 years, with a clinical diagnosis of congestive heart failure due to MC with and without immediate time relation to a common cold infection, a decreased ejection fraction, and morphologic evidence of MC on endomyocardial biopsy or an accompanying change in viral titer on follow-up (table 2) .
The control group included 98 healthy personsmostly blood donors -28 males and 70 females, ages 17-62 years.
Hypertension, lung diseases, heart valve abnormalities and coronary artery disease were excluded in each of the evaluated cases by clinical measures, including electrocardiography and echocardiography. In patients with CCM and MC, these diseases were excluded by invasive measurements of right-and leftheart pressures, ventriculography and coronary angiography.
Endomyocardial biopsies were performed from the septal part of the right ventricle with the bioptome described by Richardson.8 Experiments Peripheral blood lymphoid (PBL) cells were separated from fresh heparinized venous blood by Ficoll-Isopaque density gradient centrifugation, washed and 1224 
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Abbreviations: EF = ejection fraction; EDV = end-diastolic volume; EDVI = end-diastolic volume index; LVEDP = left ventricular end-diastolic pressure; CI = cardiac index; CCM-biopsy = morphologic characteristics of dilated cardiomyopathy. resuspended in RPMI-1640 culture medium with hepes buffer containing 1% penicillin-streptomycin, 1% L-glutamine (Gibco Europe), and 20% human ABserum (BSD/BRK). The lymphocyte:monocyte ratio of these supensions was approximately 4: 1 and did not differ substantially between groups.
Suppressor activity was induced by adding concanavalin A (Sigma Chemical Company) at'a final concentration of 60 Ag/ml to cell suspensions of 10 X 106 per 2.5 ml of culture medium' followed by incubation for 48 hours in a humidified carbon dioxide atmosphere at 37°C.9 Bystander cells were prepared in the same way except that concanavalin A was not added. Responder cells were stored for 48 hours in liquid nitrogen.
To stimulate the responder cells, we used a pool of PBL cells from five healthy, unrelated, HLA-D different donors in the mixed lymphocyte reaction (MLR); in mitogen cultures, we used protein A (Pharmacia Fine Chemicals) pokeweed mitogen (PWM) (Gibco Europe) and phytohemagglutinine (PHA) (Wellcome). To inhibit their proliferation activity, bystander, suppressor and stimulator cells were irradiated with 40 Gy by a cesium-source (Wailischmiller). The responder cells were not irradiated.
To study suppressor cell activity', we stimulated responder cells in the presence of suppressor cells with stimulator cells in a ratio of 1: 1:1.9 In separate experiments, responder cells and suppressor cells were used with mitogens (b1). Analogous stimulations of responder, bystander and stimulator cells were done separately as controls (al). Medium controls were done simultaneously (b2, a2). All experiments were performed six times. The 3H-thymidine uptake into the DNA of responder blasts was measured by liquid scintillation.
Analysis of Data
Counts per minute (cpm) were used to calculate an inhibition index for percent suppression of responder cell blastogenesis by concanavalin A-activated PBL cells according to the formula 1 -(b, -b2/a, -a2) X 100. Our calculations are based on the fact that a biologic function like suppressor cell activity must have a positive value. Therefore, an arithmetically negative suppression was taken as 0%. The t test for unpaired data with unequal variance was used to compare the values from the three groups.
Results
Suppressor cell activity in control subjects is shown in table 3. In patients with CCM, suppressor cell activity of mixed lymphocyte reactions is shown in table 4 and that of mitogen-stimulated cultures in table 5. In patients with MC, suppressor cell activity of mixed lymphocyte reactions is shown in table 6 and that of mitogen-stimulated cultures in table 7.
The suppressor cell activity of patients with CCM .71% Abbreviatio-ns: Al responder cells in the presence of allogeneic stimulator cells and autologous bystander cells; a2 = responder cells in the presence of autologous bystander cells alone; b1 = responder cells in the presence of autologous concanavalin A-treated peripheral blood mononuclear cells (PBM) and allogeneic stimulator cells; b2 = responder cells in the presence of autologous concanavalin A-treated PBM alone. groups was significantly reduced. Therefore, low suppressor cell activity may be an immunopathologic factor common to both diseases. In contrast to Fowles et al., we used a responder:suppressor/bystander: stimulator ratio of 1:1:1. To avoid the measurement of false-positive low suppressor cell activities, we introduced the control b2 (responder cells in the presence of suppressor cells against culture medium). Because concanavalin-A blasts, also irradiated, incorporate 3H-thymidine, the responder suppressor cpm b1 is usually higher than the responder bystander cpm a1. Therefore, the background control a2 alone seems insufficient (tables 4 and 6). Arithmetically negative suppression values were taken as 0%.
In the CM group, we obtained the same results as hepatitis, which also show a reduced suppressor cell activity. 13' 14 Several explanations are possible for a reduced suppressor cell activity. The suppressor cell compartment may be quantitatively reduced. A cell defect with normal cell numbers or a combination of reduced numbers and functional defect of the suppressor cells may be possible. In lupus erythematosus, for example, serum factors, as antilymphocytic autoantibodies, can attack suppressor T-lymphocytes and, by cell injury and destruction, can lead to a reduced function of the suppressor compartment. Cells from quantitatively and functionally normal compartment could also be inhibited by such serum factors. Otherwise, a low suppressor cell activity could be genetically determined as a normal variation of the immune system. Our control group showed a scattering of values around a high mean suppressor cell activity. Most controls suppress the immune response relatively strongly, but some had low suppressor cell activity. These patients may be a reservoir for autoimmune diseases or diseases with immunologic aberrations, such as CCM and MC. In 1971, Fudenberg10 suggested that all such diseases could be characterized by a disturbed suppressor cell activity. We agree that the phenomenon of low suppressor cell activity can be genetically determined. This phenomenon is present not only in SUPPRESSOR-CELL-ACTIVITY ON PHA STIMULATED CELLS CCM and MC, but also in other autoaggressive diseases, and it is independent of age in healthy persons. Therefore, reduced suppressor cell activity may indicate a genetically determined variation of the immune system. This variation may lead either alone or together with other components of immune function, coincident with specifically acting pathologic agents such as viruses, possibly with a disturbed control of the B-cell antibody synthesis, to apparent or inapparent MC and subsequently to CCM as well as to other autoimmune disorders.
Waterson16 showed that patients with CCM have higher coxsackievirus titers than controls. This incidence assumes that there could be a common cause for MC and CCM, where MC could be seen as an early stage of dilated cardiomyopathy. Our results support this concept. Reduced suppressor cell activity may well be the common important predisposing condition for both MC and CCM. Thus, these cardiomyopathies should be distinguished from cardiomyopathies of unknown etiology. 
